ArticleJournal of clinical medicine2021

RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin.

Jung Won Chun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.